New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

By Nancy Lapid March 4 (Reuters) - Ozempic, Mounjaro and other GLP-1 drugs for diabetes can prevent new substance use ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

GLP-1 drugs, like semaglutide, may help people avoid developing addictions to alcohol, tobacco, and drugs such as cannabis ...

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

A large new study suggests they may drastically reduce the risk substance use disorders and drug-related deaths.

With GLP-1 drugs becoming more accessible and affordable, they could also be within reach for substance use treatment.

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for health care A new study finds that people who quit weight-loss medications ...

Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these medications and your GLP-1 dose, she added. Also, seek ongoing guidance on diet and ...

The Cost of Weight Loss Drugs With and Without Insurance Key takeaways: Weight loss drugs can cost $200 to $2,000 monthly, depending on the medication. The ...